Tag Archive for: Medtech

Xeltis expands leadership team with appointment of Luc Verhees as Vice President of Clinical Business Development

/in

Brings over 30 years of experience in cardiovascular clinical research, business development, training, education, and medical affairs Strengthens Xeltis’ leadership team following IDE approval for initiation of US pivotal study for aXessTM, its restorative vascular access conduit EINDHOVEN, The Netherlands, 5 November 2024 – Xeltis, a leading developer of transformative implants that enable the natural […]

Read more

Biocomposites acquires remaining shares in manufacturers of SYNICEM™ and Subiton products

/in

SYNICEM™ and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers support surgeons’ infection treatment strategiesLaboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L. are the manufacturers of SYNICEM™ and Subiton products Keele, UK, 18 September 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone […]

Read more

Amber Implants Completes Enrolment of First-In-Human Clinical Trial of its VCFix® Spinal System

/in

The Hague, Netherlands, 11 June 2024: Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants for spinal injuries, today announces that it has completed enrolment of its first-in-human clinical trial with its innovative VCFix® Spinal System. The VCFix® Spinal System is the first device that does not rely on bone […]

Read more

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium

/in

Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysis aXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, long-term living vessel EINDHOVEN, The Netherlands, 17 April 2024 – Xeltis, […]

Read more

BioInnovation Institute provides financial support as six promising companies enter the Venture House program

/in

BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today announces that six companies are to receive additional financial support through its Venture House program, created to further support former Venture Lab companies through their next phase of growth. Read more…

Read more